Navigation path

FP7 projects


Project Acronym Project Title
ACTION Advance Care Planning; an Innovative Palliative Care Intervention to Improve Quality of Life in Cancer Patients - a Multi-Centre Cluster Randomized Clinical Trial
ADAMANT Antibody Derivatives as Molecular Agents for Neoplastic Targeting
ANTICARB Monoclonal ANTIbody-targeted CARBon nanotubes against cancer
ARTFORCE Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE
ATECT Advanced T-cell Engineered for Cancer Therapy
AUTOCAST Automatic Cancer Screening Based on Real-time PCR
CANCERALIA Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours
CANCERDIP The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management
CANCERPATHWAYS Developmental Molecular Pathways in Drosophila as a Model for Human Cancer
CHIBCHA Genetic study of Common Hereditary Bowel Cancers in Hispania and the Americas
COGS Collaborative Oncological Gene-environment Study
COLTHERES Modelling and predicting sensitivity to targeted therapies in colorectal cancers
CURELUNG Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis
DDRESPONSE The DNA damage response and breast cancer
DECANBIO Novel MS-based strategies to Discover and Evaluate Cancer Biomarkers in urine: Application to Diagnosis of Bladder Cancer
DIRECT DIsseminate Research funded by EC improving Treatment options for children suffering from cancer
EEC EURO EWING Consortium International Clinical Trials to Improve Survival from Ewing Sarcoma
ENS@T-CANCER European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults
EPC-TM-NET Targeting the tumour microenvironment to improve pancreatic cancer prognosis
ESMART Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers
EUROCANPLATFORM A European Platform for Translational Cancer Research
EUROCOURSE Europe against Cancer: Optimisation of the Use of Registries for Scientific Excellence in research
EUROSARC European Clinical trials in Rare Sarcomas within an integrated translational trial network
EUROTARGET European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity
GANNET53 A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer
GENICA Genomic Instability in Cancer and Precancer
GENINCA Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer
HARP Evaluation and impact of screening and treatment approaches for the prevention of cervical neoplasia in HIV-positive women in Burkina Faso and South Africa: HPV in Africa Research Partnership
HEPAVAC Cancer Vaccine development for Hepatocellular Carcinoma
HEPTROMIC Genomic predictors and oncogenic drivers in hepatocellular carcinoma
HERMIONE-2MAN First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept
HPV-AHEAD Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe
IACT Immunostimulatory Agonist antibodies for Cancer Therapy
ICREL Impact on Clinical Research of European Legislation
IMMOMEC IMmune MOdulating strategies for treatment of MErkel cell Carcinoma
IMPROVE Improving Prostate Cancer Outcome with Vectored Vaccines
INFLA-CARE Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies
INTREALL International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research
LUNGTARGET New approaches for the targeted therapy of Non-Small Cell Lung Cancer
MERCURIC A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
MERIT Mutanome Engineered RNA Immuno-Therapy
METACANCER Identification and validation of new breast cancer biomarkers based on integrated metabolomics
METAFIGHT Understanding and fighting metastasis via dissection of the Core Invasive Machinery
METOXIA Metastatic tumours facilitated by hypoxic tumour micro-environments
MICROENVIMET Understanding and fighting metastasis by modulating the tumour microenvironment through interference with the protease network
NANOPHOTO Targeted Nanosystems for Improving Photodynamic Therapy and Diagnosis of Cancer
O-PTM-BIOMARKERS Discovery of novel cancer serum biomarkers based on aberrant post translational modifications of O-glycoproteins (O-PTM-Biomarkers) and their application to early detection of cancer
OCTIPS Ovarian Cancer Therapy Innovative Models Prolong Survival
ONCOMIRS MicroRNAs and Cancer: From Bench to Bedside
OPCARE9 A European Collaboration to optimise research for the care of cancer patients in the last days of life
OPTATIO OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma
OVER-MYR Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
PANACREAS Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure
PANCARELIFE PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood
PANCARESURFUP PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
PATIENTPARTNER Identifying the Needs for Patients Partnering in Clinical Research
PREDICT Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics
PRISMA Reflecting the Positive diveRsities of European prIorities for reSearch and Measurement in end of life cAre
PROLIFICA Prevention of Liver Fibrosis and Cancer in Africa
PROMARK Genetic prostate cancer variants as biomarkers of disease progression
PROSPER Prostate cancer: profiling and evaluation of ncRNA
RATHER Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
REQUITE Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors
SFMET HGF/SF and MET in metastasis
SUPPRESSTEM Testing and validation of bispecific antibody combinations targeting treatment-resistant cancer stem cells using organoid-based screening tools: a new drug discovery paradigm
TARCC Targeting alpha-particle emitting radionuclides to combat cancer
TELOMARKER Identification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug development
TRANSCAN ERA-NET on Translational Cancer Research
TUMADOR Development of very promising fully human therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
TUMIC An integrated concept of tumor metastasis: implications for therapy
UROMOL Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors
ZF-CANCER Developing high-thoughput bioassays for human cancers in zebrafish

Top ^